What is Altimmune's long-term debt?

Altimmune (ALT) reported long-term debt of $34.51M in Q1 2026.

What is the long-term trend for Altimmune's long-term debt?

Over 3 years (2020 to 2025), Altimmune's long-term debt has grown at a 165.7% compound annual growth rate (CAGR), from $1.83M to $34.29M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Altimmune ALT Long-Term Debt

Long-Term Debt at other companies

Eli LillyLLY

$39.37B+14.1%

Merck & Co.MRK

$49.1B+41.1%

Madrigal Pharmaceuticals, Inc.MDGL

$340.33M+188%

MeiraGTx Holdings plcMGTX

$49.7M-32.4%

Beam TherapeuticsBEAM

$100.19M—

BioCryst PharmaceuticalsBCRX

$395.2M+25.3%

Other financials

Income statement

See full

Revenue$26.0K+420%

Operating income-$24.2M-11.1%

Net income-$22.6M-15.3%

EPS (diluted)-$0.18+30.8%

Balance sheet

See full

Cash & equivalents$97.6M+98.7%

Total debt$34.8M+14,092%

Total equity$284.0M+99.8%

Total assets$335.6M+113%

Cash flow

See full

Operating cash flow-$20.9M-24.4%

CapEx$21.0K—

Free cash flow-$21.0M—

Valuation

See full

Market cap$558.14M-2.1%

Enterprise value$495.27M-5.0%

P/S13,613.2×-24,380×

Profitability

See full

Operating margin-230,461%-82,087pp

Net margin-214,861%-76,057pp

FCF margin-17,806.8%-110,030pp

Returns & leverage

See full

Return on equity-42.7%-8.7pp

Debt / equity0.1×+0.1×

Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Altimmune's long-term debt?: Altimmune (ALT) reported long-term debt of $34.51M in Q1 2026.
What is the long-term trend for Altimmune's long-term debt?: Over 3 years (2020 to 2025), Altimmune's long-term debt has grown at a 165.7% compound annual growth rate (CAGR), from $1.83M to $34.29M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.